CHildhood Allergy and tolerance: bioMarkers and Predictors
Recruiting
- Conditions
- J45.9J46L20J30.1K52.2L27.2T78.0Asthma, unspecifiedStatus asthmaticusAtopic dermatitis
- Registration Number
- DRKS00015204
- Lead Sponsor
- Dr. von Haunersches Kinderspital, Ludwig-Maximilian-Universität München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
age between 0 and 17 years
Exclusion Criteria
age above 17 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are implicated in asthma and atopic dermatitis in DRKS00015204 CHAMP trial?
How do biomarkers from DRKS00015204 improve treatment outcomes for allergic rhinitis compared to standard care?
Which biomarkers in DRKS00015204 predict response to allergen-specific immunotherapy in childhood asthma?
What adverse events are reported in DRKS00015204 for patients with anaphylactic shock due to food reactions?
Are there combination therapies targeting IL-4/IL-13 pathways in DRKS00015204 for atopic dermatitis and allergic rhinitis?